Endocrine oncology

Subsequent Thyroid Carcinomas in Children and Adolescents Registered in the German MET Consortium (1997–2023)

ThyroidPublished Retrospective cohort study

Authors' conclusion

Presenting features of subsequent DTCs differ from primary counterparts, although the prognosis is not significantly different. Subsequent DTCs following chemotherapy only versus chemo- and radiotherapy DTCs were larger and diagnosed in younger patients after a shorter latency.

Study context

Population
Children and adolescents <18 years with DTC registered with the German Malignant Endocrine Tumor studies (1997–2023)
Participants
505 children
Exposure
Subsequent DTC vs first primary DTC; within subsequent DTC, chemotherapy only vs chemo- and radiotherapy
  • Subsequent DTCn = 66
  • Chemotherapy onlyn = 18
Outcome
Subsequent DTC: proportion and characteristics
Methodological detailsnational multicenter registry
  • National multicenter registry

Main finding

As reported in the abstract

Subsequent Differentiated Thyroid Carcinomas (DTCs) among all DTCs
66 (13.1%)
Median age at subsequent DTC diagnosis
12.7 years (range, 5.1-17.9)
Median latency from first malignancy or hematopoietic stem cell transplantation (HSCT)
7.3 years (range, 2.2-15.6)
5-year overall survival (OS) from subsequent DTC diagnosis
100.0%
5-year thyroid-related adverse event-free survival (EFS) from subsequent DTC diagnosis
82.5%

Observational data: associations, not effects.

Further findings

Median latency, chemotherapy only vs chemo- and radiotherapy (shorter with chemotherapy only)
6.2 vs. 7.8 years
Median size, chemotherapy only vs chemo- and radiotherapy (larger with chemotherapy only)
1.86 vs. 1.18 cm
Median age at diagnosis, chemotherapy only vs chemo- and radiotherapy (younger with chemotherapy only)
11.5 vs. 13.7 years
No differences observed for OS and EFS

Original publication

Subsequent Thyroid Carcinomas in Children and Adolescents Registered in the German MET Consortium (1997–2023). Thyroid. Published 19 December 2024. doi:10.1089/thy.2024.0312

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.